# Comparing the Efficacy of 75mg Versus 150mg Aspirin for the Prevention of Preeclampsia in High-Risk Pregnant Women

> **NCT07041385** · NA · NOT_YET_RECRUITING · sponsor: **Shalamar Hospital** · enrollment: 340 (estimated)

## Conditions studied

- Preeclampsia (PE)

## Interventions

- **DRUG:** Aspirin 75 mg
- **DRUG:** Aspirin 150 mg

## Key facts

- **NCT ID:** NCT07041385
- **Lead sponsor:** Shalamar Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2025-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07041385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07041385, "Comparing the Efficacy of 75mg Versus 150mg Aspirin for the Prevention of Preeclampsia in High-Risk Pregnant Women". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07041385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*